ICON Expands Oncology Research Network with New Illinois Cancer Institute
Event summary
- ICON's Accellacare Site Network adds the Brian Moran Cancer Institute in Illinois, expanding its oncology research capabilities.
- The new institute includes 14 medical oncologists, 3 radiation oncologists, and 9 surgical specialists.
- This partnership strengthens ICON’s ability to support oncology clinical trials and improve patient access to innovative treatments.
- Accellacare now operates 50 sites across multiple countries with over 300 research professionals.
The big picture
ICON’s expansion into the Brian Moran Cancer Institute underscores the growing demand for specialized oncology research sites. This move aligns with broader industry trends toward decentralized clinical trials and increased focus on patient-centric care models. The partnership also highlights ICON’s strategy to strengthen its investigator base, a critical factor in accelerating trial timelines.
What we're watching
- Patient Recruitment
- How the new institute will impact ICON’s ability to address patient recruitment challenges in oncology trials.
- Competitive Positioning
- Whether this expansion strengthens ICON’s competitive edge in the clinical research organization (CRO) space.
- Geographic Reach
- The pace at which ICON can scale its oncology research capabilities through additional strategic partnerships.
Related topics